XML 41 R31.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Information [Abstract]  
Schedule of Significant Expense Categories Included Net Loss Presented on Condensed Consolidated Statements of Operations and Comprehensive Loss

In addition to the significant expense categories included within net loss presented in the Company’s condensed consolidated statements of operations and comprehensive loss, see below for disaggregated amounts that comprise total operating expenses (in thousands):

 

    Three Months Ended
March 31,		  
    2026     2025  
Personnel-related costs   $ 4,038     $ 8,431  
General and overhead costs     3,291       3,611  
                 
Program costs                
Briquilimab platform     266       1,957  
CMO     882       2,138  
CSU     2,378       2,746  
Asthma     (327 )     1,393  
CIndU     424       885  
SCID     —       523  
MDS/AML     —       118  
Total program costs     3,623       9,760  
Total operating expense     10,952       21,802  
Other income, net     9,778       561  
Net loss   $ (1,174 )   $ (21,241 )